SBC Medical Group (SBC) Stock: Buy, Sell, or Hold?
SBC - SBC Medical Group Holdings Incorporated Common Stock
$4.46
0.06 (1.36%)
▲
5d:
+4.21%
30d:
+39.37%
90d:
+49.16%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When SBC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: SBC shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: SBC shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$6.79
Based on 10.7% avg growth
INTRINSIC VALUE TODAY
$4.22
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBC is currently trading at $4.46, which is considered extended relative to its 30-day fair value range of $3.39 to $4.33. The stock's valuation (Forward PE: 8.3) is in line with its historical norms (7.6). At these levels, the market is pricing in 2.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SBC is in a uptrend. The price is approaching resistance at $4.52. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SBC scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.75 (+96.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SBC is in a uptrend. The price is approaching resistance at $4.52. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SBC scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.75 (+96.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.39 -
$4.33
Company Quality Score
28/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
29.5%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 96.2% below Wall St target ($8.75)
- NEUTRAL: Market pricing in 2.8% annual earnings growth - fairly valued
- WARNING: Composite score 28/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.39 -
$4.33
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.97
Resistance Level
$4.52
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.26
Wall Street Target
$8.75
(+96.2%)
Revenue Growth (YoY)
13.4%
Earnings Growth (YoY)
338.9%
Profit Margin
28.0%
Valuation Premium vs History
+2.8% premium
PE vs Historical
8.3 vs 7.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.8%
(market-implied from PE analysis)
1-Year Target
$4.58
(+3%)
2-Year Target
$4.71
(+6%)
3-Year Target
$4.85
(+9%)
3-Yr Target (if PE normalizes)
(PE: 8→8)
PE COMPRESSION
$4.46
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 17.4%)
$17.62
(+295%)
Base:
(SPY PE: 8.3, Growth: 17.4%)
$7.22
(+62%)
Bear:
(PE: 7.0, Growth: 17.4%)
$6.13
(+38%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (9x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Trailing PE: 9.17 | Current EPS (TTM): $0.48
Bull Case
$5.45
(+22%)
Analyst growth 12.5%, PE expands to 10.1
Base Case
$4.95
(+11%)
Market implied 12.5%, PE stable at 9.2
Bear Case
$2.99
(-33%)
Severe decline -20.0%, PE contracts to 7.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: September 14, 2026 1:19 AM ET
Data refreshes hourly during market hours. Next update: 2:19 AM
Data refreshes hourly during market hours. Next update: 2:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Yoshiyuki Aikawa
SELL
3100000 shares
2026-04-21
Top Rated Consulting Services Stocks
Top-rated stocks in Consulting Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EFX
Equifax Inc |
BUY
23 analysts |
$215 | 50 HOLD |
|
HURN
Huron Consulting Group I… |
STRONG BUY
5 analysts |
$191 | 51 HOLD |
|
VRSK
Verisk Analytics Inc |
HOLD
18 analysts |
$235 | 49 HOLD |
|
BAH
Booz Allen Hamilton Hold… |
HOLD
14 analysts |
$85 | 51 HOLD |
|
ICFI
ICF International Inc |
BUY
5 analysts |
$107 | 53 HOLD |
